改良长期机械通气预后模型评分预测短期与1年死亡率
本研究回顾性纳入1288例机械通气至少14天的内科共病患者,外部验证ProVent评分并构建纳入白蛋白、胆红素及共病(慢阻肺和癌症)的扩展ProVent模型。结果显示扩展模型预测1年死亡的AUC为0.89,高于原ProVent模型的0.69。
要点
- 机械通气≥14天患者1年死亡率高,14-20天组为78.7%,≥21天组为79.9%。
- 原ProVent模型预测1年死亡AUC为0.69,扩展模型提高至0.89。
- 扩展ProVent模型纳入白蛋白、胆红素及慢阻肺和癌症共病。
核心结论
- 考虑共病与实验室数据的扩展ProVent模型可提高长期机械通气患者1年死亡率的预测能力。
研究设计与样本
- 回顾性研究,纳入1288例机械通气至少14天的患者,分为14-20天组(666例)和≥21天组(622例)。
- 在第14天(≥21天组为第21天)进行ProVent模型外部验证,并构建扩展ProVent模型。
主要发现
- ≥21天组1年死亡率为79.9%,14-20天组为78.7%。
- 除ProVent评分0和5外,各组观察死亡率大多在ProVent模型预测死亡率的95%CI内。
- 原ProVent模型预测全部≥14天机械通气患者1年死亡的AUC为0.69,扩展模型AUC为0.89。
关键数值与推荐
- 机械通气持续时间分组界值:14-20天与≥21天。
- 扩展ProVent模型纳入变量:白蛋白、胆红素、慢阻肺和癌症共病。
临床怎么用
- 对机械通气至少14天的内科共病患者,可考虑使用扩展ProVent模型评估1年死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: We aimed to validate the use of the Prolonged Mechanical Ventilation Prognostic Model (ProVent) score in medically ill patients with co-morbidities and to modify the score to improve the prediction power of 1-year mortality. METHODS: We conducted a retrospective study of all patients who required at least 14 days of mechanical ventilation (MV) and established two groups (14-20 and ≥21 days of MV) based on the MV duration. We performed external validation of the present ProVent Model in our patients on Day 14 (or Day 21 for the ≥21-day MV group) of MV, and established the extended ProVent model, while considering the albumin and bilirubin levels and co-morbidities (chronic obstructive pulmonary disease and cancer). RESULTS: A total of 1288 patients (666 and 622 with 14-20 and ≥21 days of MV, respectively) with at least 14 days of MV were enrolled. The 1-year mortality was 79.9% and 78.7% in the ≥21- and 14-20-day groups, respectively. Most of the observed mortality rates in all groups were within the 95% CI of predicted mortality as per the ProVent Model, except for the ProVent scores of 0 and 5. In the ProVent model, the area under the curve for the prediction of 1-year mortality was 0.69 in all patients with ≥14 days of MV, whereas in the extended ProVent model, the area under the curve was 0.89. CONCLUSION: The extended ProVent model, which considers co-morbidities and laboratory data, increases the prediction power of 1-year mortality in patients who require prolonged MV.
引用
- Park YR, Lee JS, Kim HJ, et al. Modification of the prolonged mechanical ventilation prognostic model score to predict short-term and 1-year mortalities. Respirology. 2018. PMID: 30223306. doi:10.1111/resp.13400
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。